Retro-1-Oligonucleotide Conjugates. Synthesis and Biological Evaluation

被引:5
作者
Agramunt, Jordi [1 ,2 ]
Pedroso, Enrique [1 ,2 ]
Kreda, Silvia M. [3 ]
Juliano, Rudolph L. [4 ]
Grandas, Anna [1 ,2 ]
机构
[1] Univ Barcelona, Dept Quim Inorgan & Organ, Secc Quim Organ, Marti i Franques 1-11, E-08028 Barcelona, Spain
[2] Univ Barcelona, IBUB, Fac Quim, Marti i Franques 1-11, E-08028 Barcelona, Spain
[3] Univ N Carolina, Sch Med, UNC Cyst Fibrosis Ctr, Chapel Hill, NC 27516 USA
[4] Univ N Carolina, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
关键词
Retro-1; oligonucleotide conjugates; antisense; splice switching; SMALL MOLECULES; DELIVERY; ANTISENSE; OLIGONUCLEOTIDE; RETRO-1; INHIBITION; ENHANCE;
D O I
10.3390/molecules24030579
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Addition of small molecule Retro-1 has been described to enhance antisense and splice switching oligonucleotides. With the aim of assessing the effect of covalently linking Retro-1 to the biologically active oligonucleotide, three different derivatives of Retro-1 were prepared that incorporated a phosphoramidite group, a thiol or a 1,3-diene, respectively. Retro-1-oligonucleotide conjugates were assembled both on-resin (coupling of the phosphoramidite) and from reactions in solution (Michael-type thiol-maleimide reaction and Diels-Alder cycloaddition). Splice switching assays with the resulting conjugates showed that they were active but that they provided little advantage over the unconjugated oligonucleotide in the well-known HeLa Luc705 reporter system.
引用
收藏
页数:17
相关论文
共 22 条
[1]   Synthesis, Chiral Separation, Absolute Configuration Assignment, and Biological Activity of Enantiomers of Retro-1 as Potent Inhibitors of Shiga Toxin [J].
Abdelkafi, Hajer ;
Michau, Aurelien ;
Clerget, Alexandra ;
Buisson, David-Alexandre ;
Johannes, Ludger ;
Gillet, Daniel ;
Barbier, Julien ;
Cintrat, Jean-Christophe .
CHEMMEDCHEM, 2015, 10 (07) :1153-1156
[2]   Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis [J].
Alam, Md Rowshon ;
Dixit, Vidula ;
Kang, Hyunmin ;
Li, Zi-Bo ;
Chen, Xiaoyuan ;
Trejo, Joann ;
Fisher, Michael ;
Juliano, Rudy L. .
NUCLEIC ACIDS RESEARCH, 2008, 36 (08) :2764-2776
[3]   Drug delivery system of therapeutic oligonucleotides [J].
Asami, Yutaro ;
Yoshioka, Kotaro ;
Nishina, Kazutaka ;
Nagata, Tetsuya ;
Yokota, Takanori .
DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (05) :256-262
[4]   Synthesis of the A/E/F sections of conaconitine, napelline and related diterpenoid alkaloids of the aconitine group [J].
Baillie, LC ;
Batsanov, A ;
Bearder, JR ;
Whiting, DA .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1998, (20) :3471-3478
[5]   Pharmacology of Antisense Drugs [J].
Bennett, C. Frank ;
Baker, Brenda F. ;
Nguyen Pham ;
Swayze, Eric ;
Geary, Richard S. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 :81-105
[6]   RNA-Targeted Therapeutics [J].
Crooke, Stanley T. ;
Witztum, Joseph L. ;
Bennett, C. Frank ;
Baker, Brenda F. .
CELL METABOLISM, 2018, 27 (04) :714-739
[7]   Overcoming cellular barriers for RNA therapeutics [J].
Dowdy, Steven F. .
NATURE BIOTECHNOLOGY, 2017, 35 (03) :222-229
[8]   Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides [J].
Juliano, Rudolph L. ;
Wang, Ling ;
Tavares, Francis ;
Brown, Edward G. ;
James, Lindsey ;
Ariyarathna, Yamuna ;
Ming, Xin ;
Mao, Chengqiong ;
Suto, Mark .
NUCLEIC ACIDS RESEARCH, 2018, 46 (04) :1601-1613
[9]   The delivery of therapeutic oligonucleotides [J].
Juliano, Rudolph L. .
NUCLEIC ACIDS RESEARCH, 2016, 44 (14) :6518-6548
[10]  
Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO